Owner Pfizer Products Inc.

Inventors Babcock, Walter Christian; Shanker, Ravi Mysore; Tadday, Ralph; Friesen, Dwayne Thomas; Smithey, Daniel Tod

Agent Shelston IP

Pub. Number AU-B-2002302903

PCT Number PCT/IB02/01792

PCT Pub. Number WO2003/000238

Priority 60/300,260 22.06.01 US

Filing date 21 May 2002

Wipo publication date 8 January 2003

Acceptance publication date 17 May 2007

A61K 9/18 (2006.01) Medicinal preparations characterised by special physical form - Adsorbates

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/404 (2006.01)

A61K 31/405 (2006.01)

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/47 (2006.01) - Quinolines

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/14 (2006.01) Drugs for disorders of the respiratory system